Shape-dependent transmembrane transport of mesenchymal stem cell membrane-coated mesoporous silica nanoparticles enhances anti-glioma therapy
Materials Today Bio · 2026-12 · 41 · 103703
DOI: 10.1016/j.mtbio.2026.103703 ↗Kurz gefasst
Fachartikel in der Zeitschrift Materials Today Bio, 2026-12. Verfasst von Yue Gong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, 213100, Ch…. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Changzhou Municipal Science and Technology Bureau.
Abstract (Originalsprache)
The blood-brain barrier (BBB) remains a major obstacle to effective glioma chemotherapy, and although mesenchymal stem cell (MSC) membrane (MSCM) coated nanoparticles offer a biomimetic strategy for glioma-targeted delivery, the role of particle morphology in such systems remains unclear. Herein, doxorubicin-loaded mesoporous silica nanoparticles coated with MSC membranes (MSCM@MSN@DOX) were developed with three morphologies-spherical (AR∼1), short rod-shaped (AR∼1.5), and long rod-shaped (AR∼3) to study the shape effect of MSC biomimetic drug delivery system on glioma treatment. All formulations showed successful membrane coating, retention of MSC-associated proteins, and comparable drug loading, release, and stability, enabling assessment of shape-dependent delivery behavior. Compared with AR∼1 and AR∼1.5 counterparts, AR∼3 particles exhibited enhanced motility, higher uptake by bEnd.3 and GL261 cells, improved trans-BBB transport, and deeper tumor spheroid penetration. Mechanistic studies suggested that these effects were associated with stronger nanoparticle-cell membrane interactions and morphology-dependent endocytic behavior. In an intracranial GL261 glioma model, AR∼3 particles achieved greater brain/glioma-region accumulation, more pronounced tumor growth inhibition, and extended survival, with no overt systemic toxicity under the tested regimen. These findings identify particle morphology as an important optimization parameter within the investigated MSC membrane-coated MSN system and provide a basis for shape optimization of this biomimetic nanocarrier platform for brain-targeted drug delivery.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, 213100, China.
- The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center of Nanjing Medical University, Pharmacy School of Nanjing Medical University, Nanjing, 211166, China.
- Department of Pharmacy, The Affiliated Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, 214400, China.
Förderung
- National Natural Science Foundation of China
- Changzhou Municipal Science and Technology Bureau
Zitieren
APA
Gong, Y., Fang, H., Li, X., He, S., Ding, Z., Xu, Y., Zhuang, T., Li, J., Zhao, W., Liu, H., Cao, X., Song, K., Shen, N., Su, D., Xin, H., & Lv, W. (2026). Shape-dependent transmembrane transport of mesenchymal stem cell membrane-coated mesoporous silica nanoparticles enhances anti-glioma therapy. Materials Today Bio, 41, 103703. https://doi.org/10.1016/j.mtbio.2026.103703
Vancouver
Gong Y, Fang H, Li X, He S, Ding Z, Xu Y, et al. Shape-dependent transmembrane transport of mesenchymal stem cell membrane-coated mesoporous silica nanoparticles enhances anti-glioma therapy. Materials Today Bio. 2026;41:103703. doi:10.1016/j.mtbio.2026.103703
BibTeX
@article{Gong2026,
author = {Gong, Yue and Fang, Hufeng and Li, Xinrui and He, Sijia and Ding, Zhenwei and Xu, Yingying and Zhuang, Tianyi and Li, Jiaxin and Zhao, Wei and Liu, Hongli and Cao, Xiang and Song, Kefan and Shen, Nan and Su, Dan and Xin, Hongliang and Lv, Wei},
title = {Shape-dependent transmembrane transport of mesenchymal stem cell membrane-coated mesoporous silica nanoparticles enhances anti-glioma therapy},
journal = {Materials Today Bio},
year = {2026},
volume = {41},
pages = {103703},
doi = {10.1016/j.mtbio.2026.103703}
}
EUVIMED